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ABSTRACT: 
Background: Attention deficit hyperactivity disorder (ADHD) is the most frequent behavioral 
disorder of childhood and is characterized by hyperactivity, attention problems and impulsivity. 
Pharmacological and behavioral therapies have been shown to be effective. In addition, the role 
of  dietary  compounds  in  the  etiology  and  possibly  the  treatment  of  ADHD  has  attracted 
increasing attention. For example, the lack of dietary essential fatty acids has been suggested to 
be associated with symptoms of ADHD in humans. 
 
Objective: To investigate the effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on 
locomotor activity in the spontaneously hypertensive rat (SHR) which has been proposed as an 
animal model of ADHD. 
 
Methods:  Two  groups  of  randomly  assigned  spontaneously  hypertensive  rats  were  fed  with 
either n-3 PUFA-deficient or n-3 PUFA-enriched food (based on AIN93G) for six weeks and this 
was  continued  during  the  phase  of  behavioral  testing.  Locomotor  activity  was  subsequently 
assessed using an open field test.  
 
Results: The results showed a marked difference in locomotor activity between the two groups 
of SHRs. In comparison with rats fed with n-3 deficient food, the animals on an n-3 enriched diet 
showed a statistically significant decrease in motor activity as assessed by the distance traveled.  
 
Conclusions:  The  present  study  demonstrates  a  marked  reduction  in  locomotor  activity 
following  an n-3 PUFA-enriched diet in SHRs, i.e. the dietary  enrichment with  n-3 PUFAs 
reduced the motor activity in an established animal model of ADHD. Dietary n-3 PUFAs may 
therefore play a role in the pathophysiology of ADHD. 
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BACKGROUND: 
Attention  deficit  hyperactivity  disorder  (ADHD)  is  the  most  frequent  behavioral  disorder  of 
childhood. The characteristic features of children and adolescents with ADHD are excessive 
motor  activity,  inattention  and  impulsiveness  [1-4].  ADHD  affects  approximately  3-5  %  of 
children  and  adolescents  worldwide,  with  a  higher  prevalence  in  boys  [5-7].  Genetic, 
neurobiological, social and environmental factors have been discussed in regard to the etiology 
of ADHD [5, 8, 9]. 
Nutrition is thought to play an important role in the behavior and cognitive functioning of 
children and dietary factors in the etiology of ADHD have been discussed [10, 11]. For example, 
it has been suggested that suboptimal omega-3 polyunsaturated fatty acid (n-3 PUFA) levels may 
contribute to ADHD symptoms. The rise in consumption of processed foods and vegetable oils 
has  markedly  increased  the  intake  of  omega-6  (n-6)  PUFAs  in  Western  diets,  while  the 
consumption of n-3 PUFAs in fish, nuts and seeds has declined. The ratio of n-3 : n-6 PUFAs has 
consequently  decreased  from  about  1  in  traditional  diets  to  approximately  1:15  [12].  Some 
studies  have  reported  that  children  with  ADHD  have  reduced  levels  of  blood  n-3  PUFAs 
compared to matched healthy control subjects [13, 14] 
 
INTRODUCTION: 
Spontaneously hypertensive rats (SHRs) were developed by inbreeding rats of the Wistar-Kyoto 
(WKY) strain. The SHR is one of the best studied animal models of ADHD. In comparison to 
WKY  rats,  SHRs  show  several  behavioral  alterations  characteristic  of  ADHD,  including 
hyperactivity, impulsivity, poor sustained attention and an impaired ability to withhold responses 
[15-19]. In the present study, we have investigated the effects of an n-3 PUFA-enriched diet 
versus an n-3 PUFA-deficient diet on locomotor behavior in SHRs using an open-field paradigm.  
 
ANIMALS AND METHODS: 
Animals. In the present study, 20 7-week-old male SHRs were used (Charles River, Sulzbach, 
Germany). The rats were housed in groups of five animals per cage and kept on a 12:12 h light-
dark cycle (room temperature 22 ºC, humidity 50 %). They were given free access to water and 
the experimental diet, except for the behavioral testing period. At the beginning of the behavioral 
experiments  water  was  provided  ad  libitum  but  food  was  restricted  in  order  to  prepare  the 
animals for the experiments and to increase their motivation.  
The rats were at randomly assigned to two groups, i.e. group 1 (n-3 PUFA-enriched, n=10) 
received a diet enriched in n-3 PUFAs (Ssniff, Soest, Germany; based on AIN93G, for details 
see Table 1), while group 2 (n-3 PUFA-deficient, n=10) was fed with a diet deficient in n-3 
PUFAs  (see  Table  1).  The  experimental  diets  were  provided  for  six  weeks  and  during  the 
subsequent phase of behavioral testing. 
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Table 1. Fatty acid composition of the experimental diets based on the AIN93G 
composition (source: Ssniff Spezialdiäten, Soest, Germany) 
_____________________________________________________________________ 
        n-3 PUFA-enriched diet  n-3 PUFA-deficient dieT 
_____________________________________________________________________ 
Energy (Atwater), MJ/kg*    17.1        17.1 
kJ% protein        18        18 
kJ% carbohydrates      60        60 
kJ% fat          22        22 
 
Fatty acids, % of diet 
C 6:0          0.05        0.05 
C 8:0          0.59        0.62 
C 10:0          0.47        0.49 
C 12:0          3.48        3.64 
C 14:0          1.35        1.41 
C 16:0          0.84        0.85 
C 18:0          0.29        0.28 
C 20:0          0.01        0.01 
C 18:1          0.82        0.77 
C 18:2 n6        1.54        1.58 
C 18:3 n3        0.27        0.01 
____________________________________________________________________ 
* Physiological fuel value 
 
Apparatus: The rats’ locomotor activity was measured in an open field. The open field used 
consisted of a rectangular arena (size: 82.5 x 82.5 cm with walls 40 cm high), made of dark gray 
synthetic material. The locomotor activity was recorded by a fixed digital video system. This 
data was digitized and analyzed using the video tracking system ETHOVISION 3.0 (Noldus, 
Wageningen, The Netherlands). The distance traveled in the open field over 15 minutes was 
recorded.  
 
Procedure: Rats were tested once daily for six consecutive days. Each rat was  individually 
placed in the center of the open field and allowed to explore freely for 15 minutes. Prior to each 
trial all open-field surfaces were cleaned with 70 % alcohol in order to remove odors and/or 
residues of rats tested previously. The rats were tested each day in random order. The animals’ 
body weight was measured daily in order to ensure normal weight gain and to prevent a weight 
loss of more than 10 %. At the time of behavioral testing, there were no significant differences in 
body weight between the two experimental groups.  
 
Statistics: The statistical analysis of differences between the two groups (n-3 PUFA-enriched 
and n-3 PUFA-deficient) was performed with Mann-Whitney U-test using the Statistical Package 
for Social Sciences 17.0 (SPSS) for Windows. An alpha level of .05 was applied.   centre Functional Foods in Health and Disease 2013; 3(6):223-229                                                        Page 226 of 229 
Ethics: This study was performed in accordance with national laws (German Law on Protection 
of Animals) and European laws, and the principles of laboratory animal care (NIH publication 
No. 86-23, revised 1985).  
 
RESULTS: 
The locomotor activity on six consecutive days (i.e. the distance travelled within 15 minutes) of 
SHRs following consumption of n-3 deficient or n-3 enriched diet for six weeks (plus six days of 
testing)  is  given  in  Table  2.  The  distance  travelled  of  the  n-3  deficient  SHR  group  was 
significantly increased on days 2, 4, 5, 6 and over the total of 6 days when compared to the 
animals fed with the n-3 enriched diet. 
 
Table 2. Distance travelled in the open field of the n-3 PUFA-deficient and n-3 PUFA-enriched 
SHR groups (means  ± standard errors)  
_________________________________________________________________________ 
      n-3 PUFA-deficient  n-3 PUFA-enriched  p-value  z-value 
_________________________________________________________________________ 
Day 1      5858.6 ± 156.6  5526.0 ± 191.2  0.226    -1.21 
Day 2      6114.8 ± 242.5 *  4997.1 ± 257.6  0.013    -2.50 
Day 3      5014.1 ± 181.2  5108.5 ± 251.4  1    0 
Day 4      5664.2 ± 158.7 *  4843.0 ± 162.9  0.003    -2.95 
Day 5      5333.9 ± 320.3 *  4381.6 ± 151.0  0.023    -2.27 
Day 6      5549.4 ± 317.2 *  4578.7 ± 205.0  0.041    -2.04 
 
Days 1-6 (mean)  5589.2 ± 165.5 *  4905.80 ± 130.2  0.007    -2.72 
_________________________________________________________________________ 
* p < .05 compared to n-3 PUFA-enriched group 
 
DISCUSSION: 
Long-chain PUFAs are essential for the central nervous system, e.g. the most predominant n-3 
PUFA  in  the  brain,  docosahexaenoic  acid  (DHA)  [20,  21],  increases  cellular  membrane 
flexibility and is involved in the regulation of neurotransmission, myelination, and other cellular 
activities. An impoverished n-3 PUFA diet in rodents over several generations has been shown to 
result in a 50 to 80 % deficit in brain DHA phospholipids and in cognitive deficits including the 
performance in spatial learning and other learning tasks [22-24]. 
Dietary factors including the dietary lack of n-3 PUFAs have been discussed in regard to 
dyfunctions found in ADHD [for review of animal research see 25]. Several clinical trials with 
mixed  results  have  been  conducted  to  investigate  whether  some  behavioral  or  cognitive 
symptoms of children with ADHD can be improved by long-chain PUFA supplementation [26]. 
Locomotor hyperactivity is the most easily discerned symptom of ADHD. The present study 
investigated the effects of a diet rich or impoverished in n-3 PUFAs on locomotor activity in rats 
using an open-field paradigm. We have used SHRs which have been proposed as an animal 
model of ADHD [e.g. 19]. Functional Foods in Health and Disease 2013; 3(6):223-229                                                        Page 227 of 229 
The present results showed a marked difference in locomotor activity between the two 
groups of SHRs. In comparison with rats fed with n-3 PUFA-deficient food, the animals on an n-
3 PUFA-enriched diet showed a statistically significant decrease in motor activity as assessed by 
the distance traveled in the open field. 
Previous studies investigating the role of dietary PUFAs on locomotion in rodents reported 
inconsistent findings. A study in mice investigating the effects of a diet deficient in α-linolenic 
acid  followed  or  not  by  supplementation  with  phospholipids  rich  in  n-3  PUFAs  found  no 
significant effect between diet groups on open-field motor activity [27]. A fish oil enriched diet 
was reported to reduce ambulatory activity in Wistar rats [28].  In SHRs, dams were given n-3 
PUFA-enriched feed during pregnancy and their offspring continued on this diet [29]. This study 
showed an n-3 PUFA-induced reduction in spontaneous locomotion.  
Given the hypothesis that SHR is a valid animal model of ADHD symptoms including 
hyperactivity [for critical review see 30], one could conclude from our data that the diet enriched 
with n-3 PUFAs reduced the rats’ hyperactivity. However, the present results were obtained by 
comparison with animals fed with n-3 PUFA-deficient food. Further studies are therefore needed 
in order to establish if the (hyper) activity of SHRs can also be ameliorated when the animals are 
fed with a balanced diet. In addition, it remains of interest whether other ADHD core symptoms 
such as inattention or impulsivity are affected by dietary n-3 PUFAs.   
 
CONCLUSIONS: 
The  present  study  demonstrated  a  marked  reduction  in  locomotor  activity  following  an  n-3 
PUFA-enriched diet in SHRs, i.e. the dietary enrichment with n-3 PUFAs reduced the activity in 
an established animal model of ADHD when compared with an n-3 PUFA-deficient diet. Dietary 
n-3 PUFAs appear to affect locomotor activity in rats and may play a role in the pathophysiology 
of ADHD. 
 
Competing Interests: The authors have no financial interests or conflicts of interest. 
 
Authors’ Contributions: All authors contributed to this study. 
 
Abbreviations: ADHD, attention deficit hyperactivity disorder; DHA, docosahexaenoic acid; n-
3 PUFA, omega-3 polyunsaturated fatty acid; n-6 PUFA, omega-6 polyunsaturated fatty acid; 
SHR, spontaneously hyperactive rat. 
 
 
REFERENCES: 
1.  Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit 
hyperactivity disorder. Atten Defic Hyperact Disord 2010; 2(4): 241-55. 
2.  Tucha O, Prell S, Mecklinger L, Bormann-Kischkel C, Kübber S, Linder M, Walitza S, 
Lange KW. Effects of methylphenidate on multiple components of attention in children 
with attention deficit hyperactivity disorder. Psychopharmacology 2006; 185: 315-326. 
3.  Tucha  O,  Walitza  S,  Mecklinger  L,  Sontag  TA,  Kübber  S,  Linder  M,  Lange  KW. 
Attentional functioning in children with ADHD - predominantly hyperactive-impulsive Functional Foods in Health and Disease 2013; 3(6):223-229                                                        Page 228 of 229 
type and children with ADHD - combined type. Journal of Neural Transmission 2006; 
113: 1943-1953. 
4.  Lange KW, Tucha L, Walitza S, Gerlach M, Linder M, Tucha O. Interaction of attention 
and graphomotor functions in children with attention deficit hyperactivity disorder. J 
Neural Transm Suppl 2007; 72: 249-59. 
5.  Barkley  RA.  Attention-Deficit  Hyperactive  Disorder:  a  handbook  for  diagnosis  and 
treatment. London: Guilford Press, 2006. 
6.  Clements KM, Girard TA, Xing HC, Wainwright PE. Spontaneously hypertensive and 
Wistar  Kyoto  rats  differ  in  delayed  matching-to-place  performance  and  response  to 
dietary long-chain polyunsaturated fatty acids. Dev Psychobiol 2003; 43: 57-69. 
7.  Paule M, Rowland A, Ferguson S, Chelonis J, Tannock R, Swanson J, Castellanos F. 
Attention  Deficit/Hyperactivity  Disorder:  Characteristics,  Interventions,  and  Models. 
Neurotoxicol Teratol 2000; 22: 631-651. 
8.  Biederman  J,  Faraone  SV.  Attention‐deficit/hyperactivity  disorder.  The  Lancet  2005; 
366(9481): 237‐248. 
9.  Vancassel  S,  Blondeau  C,  Lallemand  S,  Chador  M,  Linard  A,  Lavialle  M,  Dellu-
Hagedorn F. Hyperactivity in the rat is associated with spontaneous low level of n-3 
polyunsaturated fatty acids in the frontal cortex. Behav Brain Res 2007; 180: 119-126. 
10. Wainwright  PE.  Dietary  essential  fatty  acids  and  brain  function:  a  developmental 
perspective on mechanisms. Proc Nutr Soc 2002; 61: 61-69. 
11. Schuchardt  JP,  Huss  M,  Stauss-Grabo  M,  Hahn  A.  Significance  of  long-chain 
polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur 
J Pediatr 2010; 169: 149-164. 
12. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. 
Biomed Pharmacother 2002; 56(8): 365-79. 
13. Richardson AJ. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. 
Int Rev Psychiatry 2006; 18(2): 155-72. 
14. Young G, Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr 
Dev 2005; 45(1): 1-28. 
15. Berger  DF,  Sagvolden  T.  Sex  differences  in  operant  discrimination  behaviour  in  an 
animal model of attention-deficit hyperactivity disorder. Behav Brain Res 1998; 94(1): 
73-82. 
16. Boix F, Qiao SW, Kolpus T, Sagvolden T. Chronic L-deprenyl treatment alters brain 
monoamine  levels  and  reduces  impulsiveness  in  an  animal  model  of  Attention-
Deficit/Hyperactivity Disorder. Behav Brain Res 1998; 94(1): 153-62. 
17. Johansen EB, Sagvolden T. Response disinhibition may be explained as an extinction 
deficit in  an animal model  of  attention-deficit/hyperactivity disorder  (ADHD).  Behav 
Brain Res 2004; 149(2): 183-96. 
18. Russell  VA,  de  Villiers  AS,  Sagvolden  T,  Lamm  MC,  Taljaard  JJ.  Methylphenidate 
affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity 
disorder--the spontaneously hypertensive rat. Brain Res Bull 2000; 53(2): 187-92. Functional Foods in Health and Disease 2013; 3(6):223-229                                                        Page 229 of 229 
19. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an 
animal  model  of  attention-deficit/hyperactivity  disorder  (AD/HD).  Neurosci  Biobehav 
Rev 2000; 24: 31-39. 
20. Sastry PS. Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 1985; 
24(2): 69-176. 
21. Spector AA. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty 
acid for the brain. J Mol Neurosci 2001; 16(2-3): 159-65. 
22. de Souza AS, Pacheco Lda C, Castro Pda S, Hokoç JN, Rocha MS, do Carmo Md. Brain 
fatty  acid  profiles  and  spatial  learning  in  malnourished  rats:  effects  of  nutritional 
intervention. Nutr Neurosci 2008; 11(3): 119-27. 
23. Fedorova I, Hussein N, Baumann MH, Di Martino C, Salem N Jr. An n-3 fatty acid 
deficiency impairs rat spatial learning in the Barnes maze. Behav Neurosci 2009; 123(1): 
196-205. 
24. Vancassel  S, Aïd S, Pifferi F, Morice E, Nosten-Bertrand M,  Chalon  S, Lavialle M. 
Cerebral  asymmetry  and  behavioral  lateralization  in  rats  chronically  lacking  n-3 
polyunsaturated fatty acids. Biol Psychiatry 2005; 58(10): 805-11. 
25. Transler C, Mitchell S, Eilander A. Could polyunsaturated fatty acids deficiency explain 
some dysfunctions found in ADHD? Hypotheses from animal research. J Atten Disord 
2013; 17(1): 20-28. 
26. Transler C, Eilander A, Mitchell S, van de Meer N. The impact of polyunsaturated fatty 
acids in reducing child attention deficit and hyperactivity disorders. J Atten Disord 2010; 
14(3): 232-46. 
27. Carrié I, Clément M, de Javel D, Francès H, Bourre JM. Phospholipid supplementation 
reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid 
deficiency in mice. J Lipid Res 2000; 41(3): 473-80. 
28. Chalon S, Delion-Vancassel S, Belzung C, Guilloteau D, Leguisquet AM, Besnard JC, 
Durand G. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. 
J Nutr 1998; 128: 2512-9. 
29. Dervola KS, Roberg BA, Wøien G, Bogen IL, Sandvik TH, Sagvolden T, Drevon CA, 
Johansen EB, Walaas SI. Marine omega-3 polyunsaturated fatty acids induce sex-specific 
changes  in  reinforcer-controlled  behaviour  and  neurotransmitter  metabolism  in  a 
spontaneously hypertensive rat model of ADHD. Behav Brain Funct 2012; 8: 56. 
30. Sontag  TA,  Tucha  O,  Walitza  S,  Lange  KW.  Animal  models  of  attention 
deficit/hyperactivity  disorder  (ADHD):  a  critical  review.  Atten  Defic  Hyperact  Disord 
2010; 2(1): 1-20.  